文
论文分享
演练场
杂货铺
论文推荐
字
编辑器下载
登录
注册
J. Funk
发表
Phase II trial of ipilimumab in melanoma patients with preexisting humoural immune response to NY-ESO-1.
A. Enk, N. Halama, L. Umansky, 2018, European journal of cancer.